No stock? The governors killed Washington as a pile of vaccine chokepoints

0
15

If you ask the New Jersey government. Why would Phil Murphy Kovid-19 vaccination be so slow, he would say the answer is simple.

“The hurdle is 100 percent, which is currently supplied from the Feds,” said Murphy of Democratic TV on Thursday.

Ask the Feds, and they will say that they have delivered far higher doses than states that are leaving the vaccine on the shelf.

“During this process, some states’ heavy microconsciousness has become in the path of vaccines reaching vulnerable populations,” US Secretary of Health and Human Services Alex Azar said in a briefing on Tuesday. Out of special states.

And if you ask the vaccine manufacturers, they will say that the problem is not on their side.

“I don’t think we have a problem offering fewer vaccines than countries. We still have more that they can use.

A vaccine rollout in a month that has fallen short of everyone’s expectations, blamed for defect hiccups, which is advancing and many times threatening to interrupt vaccination. And it is disappointing public health experts, who say the Trump administration’s coronovirus vaccination team is sleeping in its last days.

On Friday, several governors accused Azar of betraying them as to what dose they could expect in the near future. Azar said on Tuesday that the Trump administration was planning to release a strategic reserve of doses that were holding back for booster shots, but governors said they learned there is no reserve because it has been since this week Had already been released.

“I’m Seeking Answers From The Trump Administration,” Oregon Gov. Kate Brown, A Democrat, Said on twitter on friday.

He said, “I am shocked and disappointed that she has expressed hope on which she could not give serious results”. “This is a hoax at the national level.”

Disappointing vaccine delivery, if it does not improve, could be a major missed opportunity to save lives in the form of the highest wave of epidemics at approximately 200,000 new cases per day. Coronovirus is the cause of 4,000 deaths per day in the US

The former director of the Center for Disease Control and Drs. Tom Frieden said, “This requires a whole-government, whole-society approach, and instead what we’re looking at is a finger-pointing approach.” Prevention.

Freiden said in an interview that while there is little basic information available about where the country’s vaccine supplements are and what is coming, it is difficult to know where the bottlenecks are. But he said Borla’s remarks about adequate supplies were “nonsense” and that Azhar was influencing the situation.

“Secretary Azar’s remarks have been unattainable. They have been misleading and inaccurate and confusing, ”said Freiden, CEO of the health nonprofit Resolve Saves Lives.

The nation’s halt to start vaccination of Kovid-19 has been triggered by a number of failures, including the lack of more Congress funding in December and months of less-than-planned planning in many states and territories that the dose will come Will be.

States are still lagging behind, as data from the CDC showed that only 36 percent of the doses distributed to the states were given to the people. But this week, as states increase the number of immunization sites, the focus on supply bottlenecks has begun.

Oregon discovered the latest supply problem late Thursday when the state’s vaccine program manager entered the federal system to allocate vaccines to place an order and noticed there were no additional supplements, according to a person familiar with the state’s program According to who spoke on condition of anonymity. State officials spoke on the phone with federal officials and confirmed that there would be no additional supplements for states to receive, the person said.

Oregon Health Authority director Patrick Allen sent a letter to the Trump administration seeking clarification on the federal government’s vaccine list. The letter was first reported by The Washington Post.

Several states, including Oregon and New Jersey, plan to extend eligibility for vaccination to people 65 and older, with the expectation that the supply will be further emphasized by Azar’s recommendation.

Philadelphia’s Department of Public Health said in a statement, “We are no longer expecting the growth of promises like Azar and we are not considering changing our priority plan to allow wider delivery. We are concerned that the amount we will receive after January will be less than the amount we are receiving now. “

New York Governor Andrew Cuomo, a Democrat, said his state’s allocation from the federal government on Friday was set to go from 300,000 doses this week to 250,000 doses next week.

Azar’s office did not immediately respond to Friday’s request for comment. His days in government are limited, with President-Elect Joe Biden named California Attorney General Javier Becerra as his successor.

The Chief Medical Officer of the Association of State and Territorial Health Officials Drs. Marcus Placia said his organization had not given a clear answer on the federal government’s reserve of vaccine doses.

“We’re getting mixed information on this,” he said. “But if there is no release of the doses kept in reserve, we may be challenged to raise health care workers and other groups beyond the LTCF in the near future,” he said, referring to long-term care facilities .

Pfizer, which along with its partner BioNTech, is making one of the two vaccines approved in the US, announced this week that it was raising its production estimate to 2 billion doses by the end of 2021 from the previous forecast of 1.3 billion. The US is scheduled to receive 200 million doses from Pfizer-BioNTech as of July 31.

Asked about complaints from governors that there was a shortage of supplies, Pfizer said in a statement on Thursday that it was on track.

“Rest assured that Pfizer is working around the clock and is ready to release millions of doses each day and that volume is increasing as our commercial ramps progress,” the company said.

A manufacturer of other US-approved vaccines, Modern estimated its production from 500 million doses to 600 million doses for 2021 earlier this month. It said it continues to add staff to potentially create 1 billion doses for 2021.

Nevertheless, some public health experts said they were struggling to see any part of the vaccine supply chain that was working well.

“It’s a complex system, and if you look at the data that we have so far, there are all the problems and bottlenecks and holdups with the system,” said Bruce Y. Lee, a professor of public health and health policy in the city. Executive Director of New York University and the University’s PHICOR Research Team.

“Where is it being held?” Clearly, many places, ”he said.

Lee said there is a need to create more coordination by the federal government, including better doses not being properly used, where there is a shortage of syringes and people trained to manage vaccination and solve problems Clear guidance on what to do. Dose from the vials of leftover kiosks.

“The federal government is an entity with the resources and freedom and authority to overcome problems in the supply chain,” he said.

Freeden, who served as CDC director under President Barack Obama, said he expected the incoming Biden administration to be more organized.

“If you offer a vaccination program to people who have never run an immunization program, don’t expect it to run smoothly,” he said. “The CDC knows how to do it. The CDC is the agency that should lead it, but they have been sidelined.

LEAVE A REPLY

Please enter your comment!
Please enter your name here